de Northern Trust Ironwood Pharmaceuticals IRWD Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 5.78 M | Comprar |
1,373,974
+108,132
| +9% | +USD 417 k | ﹤0.01% | 2533 |
|
|
2026
Q1 | USD 4.44 M | Comprar |
1,265,842
+32,157
| +3% | +USD 132 k | ﹤0.01% | 2523 |
|
|
2025
Q4 | USD 4.16 M | Vender |
1,233,685
-107,221
| -8% | -USD 278 k | ﹤0.01% | 2580 |
|
|
2025
Q3 | USD 1.76 M | Comprar |
1,340,906
+35,641
| +3% | +USD 36.9 k | ﹤0.01% | 3109 |
|
|
2025
Q2 | USD 936 k | Vender |
1,305,265
-101,269
| -7% | -USD 79.5 k | ﹤0.01% | 3433 |
|
|
2025
Q1 | USD 2.07 M | Vender |
1,406,534
-218,576
| -13% | -USD 521 k | ﹤0.01% | 2909 |
|
|
2024
Q4 | USD 7.2 M | Comprar |
1,625,110
+118,962
| +8% | +USD 483 k | ﹤0.01% | 2312 |
|
|
2024
Q3 | USD 6.21 M | Comprar |
1,506,148
+29,605
| +2% | +USD 159 k | ﹤0.01% | 2357 |
|
|
2024
Q2 | USD 9.6 M | Vender |
1,476,543
-55,974
| -4% | -USD 396 k | ﹤0.01% | 2021 |
|
|
2024
Q1 | USD 13.3 M | Vender |
1,532,517
-55,875
| -4% | -USD 678 k | ﹤0.01% | 1871 |
|
|
2023
Q4 | USD 18.2 M | Vender |
1,588,392
-53,495
| -3% | -USD 529 k | ﹤0.01% | 1679 |
|
|
2023
Q3 | USD 15.8 M | Comprar |
1,641,887
+3,268
| +0.2% | +USD 32 k | ﹤0.01% | 1708 |
|
|
2023
Q2 | USD 17.4 M | Comprar |
1,638,619
+74
| +0% | +USD 795 | ﹤0.01% | 1686 |
|
|
2023
Q1 | USD 17.2 M | Comprar |
1,638,545
+7,966
| +0.5% | +USD 89.2 k | ﹤0.01% | 1646 |
|
|
2022
Q4 | USD 20.2 M | Comprar |
1,630,579
+68,486
| +4% | +USD 777 k | ﹤0.01% | 1511 |
|
|
2022
Q3 | USD 16.2 M | Vender |
1,562,093
-76,800
| -5% | -USD 871 k | ﹤0.01% | 1641 |
|
|
2022
Q2 | USD 18.9 M | Comprar |
1,638,893
+17,553
| +1% | +USD 207 k | ﹤0.01% | 1560 |
|
|
2022
Q1 | USD 20.4 M | Vender |
1,621,340
-62,030
| -4% | -USD 711 k | ﹤0.01% | 1659 |
|
|
2021
Q4 | USD 19.6 M | Vender |
1,683,370
-45,513
| -3% | -USD 558 k | ﹤0.01% | 1781 |
|
|
2021
Q3 | USD 22.6 M | Vender |
1,728,883
-1,533
| -0.1% | -USD 19.8 k | ﹤0.01% | 1717 |
|
|
2021
Q2 | USD 22.3 M | Vender |
1,730,416
-124,284
| -7% | -USD 1.42 M | ﹤0.01% | 1808 |
|
|
2021
Q1 | USD 20.7 M | Vender |
1,854,700
-121,731
| -6% | -USD 1.29 M | ﹤0.01% | 1800 |
|
|
2020
Q4 | USD 22.5 M | Vender |
1,976,431
-61,818
| -3% | -USD 676 k | ﹤0.01% | 1704 |
|
|
2020
Q3 | USD 18.3 M | Vender |
2,038,249
-124,734
| -6% | -USD 1.24 M | ﹤0.01% | 1702 |
|
|
2020
Q2 | USD 22.3 M | Comprar |
2,162,983
+115,445
| +6% | +USD 1.18 M | 0.01% | 1521 |
|
|
2020
Q1 | USD 20.7 M | Comprar |
2,047,538
+46,912
| +2% | +USD 551 k | 0.01% | 1380 |
|
|
2019
Q4 | USD 26.6 M | Comprar |
2,000,626
+43,271
| +2% | +USD 477 k | 0.01% | 1495 |
|
|
2019
Q3 | USD 16.8 M | Comprar |
1,957,355
+169,902
| +10% | +USD 1.65 M | ﹤0.01% | 1814 |
|
|
2019
Q2 | USD 19.6 M | Vender |
1,787,453
-306,817
| -15% | -USD 3.44 M | ﹤0.01% | 1708 |
|
|
2019
Q1 | USD 23.7 M | Comprar |
2,094,270
+49,988
| +2% | +USD 558 k | 0.01% | 1543 |
|
|
2018
Q4 | USD 17.7 M | Comprar |
2,044,282
+39,410
| +2% | +USD 452 k | 0.01% | 1678 |
|
|
2018
Q3 | USD 31 M | Comprar |
2,004,872
+44,484
| +2% | +USD 703 k | 0.01% | 1424 |
|
|
2018
Q2 | USD 31.4 M | Comprar |
1,960,388
+95,639
| +5% | +USD 1.42 M | 0.01% | 1402 |
|
|
2018
Q1 | USD 24.1 M | Comprar |
1,864,749
+5,508
| +0.3% | +USD 68.6 k | 0.01% | 1540 |
|
|
2017
Q4 | USD 23.3 M | Vender |
1,859,241
-53,645
| -3% | -USD 701 k | 0.01% | 1591 |
|
|
2017
Q3 | USD 25.3 M | Vender |
1,912,886
-26,490
| -1% | -USD 365 k | 0.01% | 1543 |
|
|
2017
Q2 | USD 30.7 M | Comprar |
1,939,376
+105,626
| +6% | +USD 1.53 M | 0.01% | 1349 |
|
|
2017
Q1 | USD 26.2 M | Comprar |
1,833,750
+30,069
| +2% | +USD 411 k | 0.01% | 1434 |
|
|
2016
Q4 | USD 23.1 M | Vender |
1,803,681
-304,230
| -14% | -USD 3.84 M | 0.01% | 1501 |
|
|
2016
Q3 | USD 28 M | Vender |
2,107,911
-3,574
| -0.2% | -USD 41.8 k | 0.01% | 1310 |
|
|
2016
Q2 | USD 23.1 M | Comprar |
2,111,485
+34,405
| +2% | +USD 336 k | 0.01% | 1419 |
|
|
2016
Q1 | USD 18.9 M | Comprar |
2,077,080
+36,472
| +2% | +USD 301 k | 0.01% | 1533 |
|
|
2015
Q4 | USD 19.8 M | Comprar |
2,040,608
+44,792
| +2% | +USD 433 k | 0.01% | 1520 |
|
|
2015
Q3 | USD 17.4 M | Comprar |
1,995,816
+82,049
| +4% | +USD 766 k | 0.01% | 1594 |
|
|
2015
Q2 | USD 19.3 M | Vender |
1,913,767
-23,414
| -1% | -USD 272 k | 0.01% | 1617 |
|
|
2015
Q1 | USD 26 M | Comprar |
1,937,181
+30,158
| +2% | +USD 396 k | 0.01% | 1369 |
|
|
2014
Q4 | USD 24.5 M | Vender |
1,907,023
-77,847
| -4% | -USD 891 k | 0.01% | 1376 |
|
|
2014
Q3 | USD 21.5 M | Comprar |
1,984,870
+431,924
| +28% | +USD 4.94 M | 0.01% | 1455 |
|
|
2014
Q2 | USD 19.9 M | Vender |
1,552,946
-511,315
| -25% | -USD 5.56 M | 0.01% | 1522 |
|
|
2014
Q1 | USD 21.3 M | Comprar |
2,064,261
+463,491
| +29% | +USD 5.21 M | 0.01% | 1523 |
|
|
2013
Q4 | USD 15.6 M | Comprar |
1,600,770
+22,093
| +1% | +USD 198 k | 0.01% | 1736 |
|
|
2013
Q3 | USD 15.7 M | Comprar |
1,578,677
+102,895
| +7% | +USD 1.01 M | 0.01% | 1671 |
|
|
2013
Q2 | USD 12.3 M | Comprar |
+1,475,782
| Nuevas | +USD 17.9 M | ﹤0.01% | 1767 |
|
Otros fondos que tienen IRWD en su cartera
Posición de Northern Trust en IRWD: resumen de T2 2026
Northern Trust aumentó su participación en Ironwood Pharmaceuticals (IRWD) en 8.5% durante T2 2026, al comprar aproximadamente USD 417 k y elevar la posición a 1,373,974 acciones con un valor de USD 5.78 M. La posición representa ﹤0.01% de la cartera y ocupa el puesto #2533.
Northern Trust reportó por primera vez una posición en IRWD en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. La posición alcanzó su máximo de USD 31.4 M en T2 2018. Al cierre de T2 2026, 212 fondos que sigue Wall St. Rank mantienen una posición en IRWD.
- Al cierre de T2 2026, Northern Trust tenía 1,373,974 acciones de Ironwood Pharmaceuticals con un valor de USD 5.78 M.
- Northern Trust compró 108,132 acciones de Ironwood Pharmaceuticals en T2 2026, por un monto estimado de USD 417 k.
- Ironwood Pharmaceuticals representó ﹤0.01% de la cartera de Northern Trust en T2 2026 y fue su posición número 2533.
- Northern Trust reportó por primera vez una posición en Ironwood Pharmaceuticals en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- La posición de Northern Trust en Ironwood Pharmaceuticals alcanzó su máximo de USD 31.4 M en T2 2018.
- Al cierre de T2 2026, 212 fondos que sigue Wall St. Rank tenían Ironwood Pharmaceuticals en cartera.
Según el Informe 13F de Northern Trust correspondiente a T2 2026, presentado el 13 ago 2026.